Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance. The positive recommendation follows an improved patient access scheme by the company as part of a commercial arrangement. The draft […]